Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

NCT01242072 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignancy
Cancer
Non Small Cell Lung Cancer
Small Cell Lung Cancer
Testicular Cancer
Thymoma
Ovarian Cancer
Osteosarcoma

Interventions

DRUG: palifosfamide-tris

Sponsor

Alaunos Therapeutics